European Union leaders are divided over whether to follow Washington in supporting a waiver of patent rights to COVID-19 vaccines, as many argue this would take years and not address the immediate issue of making more shots to end the pandemic. Leaders of the 27-nation bloc will discuss the patent waiver idea at a two-day summit that starts in the Portuguese city of Porto on Friday, but are unlikely to formulate a strong united position apart from a general readiness to discuss the topic. U.S. President Joe Biden on Wednesday backed waiving intellectual property rights for COVID-19 vaccines, responding to pressure from Democratic lawmakers and more than 100 other countries, but angering pharmaceutical companies.
Residents of a Rio de Janeiro slum accuse police of violence and abuses in a raid that left 25 dead.
Dow Jones futures rose ahead of the April jobs report. Roku and Cloudflare led late earnings as the Fed warned asset prices risk "significant declines."